To evaluate this hypothesis, we monitored the expression level of several mesenchymal markers, including SNAIL1, SLUG, ZEB, TWIST, and c-Myc in HT29, FET, and SW480 cancer cells after treatment with NS1643. The gene discussed is MYC; the disease is cancer.